Free Trial

Charles River Laboratories International (CRL) SEC Filings & 10K Form

Charles River Laboratories International logo
$185.77 +3.62 (+1.99%)
(As of 12/20/2024 05:45 PM ET)

Recent Charles River Laboratories International SEC Filings

DateFilerForm TypeView
12/13/2024
3:42 PM
Charles River Laboratories International (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/08/2024
5:21 PM
Barbo William D (Reporting)
Charles River Laboratories International (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/08/2024
4:31 PM
BlackRock, Inc. (Filed by)
Charles River Laboratories International (Subject)
Form SC 13G/A
11/08/2024
9:52 AM
Charles River Laboratories International (Subject)
WELLINGTON MANAGEMENT GROUP LLP (Filed by)
Form SC 13G
11/07/2024
3:23 PM
Charles River Laboratories International (Subject)
WALLMAN RICHARD F (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/06/2024
8:16 AM
Charles River Laboratories International (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
11/06/2024
6:21 AM
Charles River Laboratories International (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/22/2024
2:24 PM
BlackRock, Inc. (Filed by)
Charles River Laboratories International (Subject)
Form SC 13G/A
08/13/2024
3:17 PM
Charles River Laboratories International (Issuer)
FOSTER JAMES C (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/12/2024
3:13 PM
Charles River Laboratories International (Issuer)
LaPlume Joseph W (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/08/2024
12:34 PM
Charles River Laboratories International (Subject)
LaPlume Joseph W (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/07/2024
8:15 AM
Charles River Laboratories International (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
08/07/2024
6:21 AM
Charles River Laboratories International (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/04/2024
3:46 PM
Charles River Laboratories International (Issuer)
LaPlume Joseph W (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/04/2024
3:17 PM
Charles River Laboratories International (Issuer)
Pease Flavia (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/03/2024
3:37 PM
Charles River Laboratories International (Issuer)
LaPlume Joseph W (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/30/2024
7:05 PM
Barbo William D (Reporting)
Charles River Laboratories International (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/30/2024
7:18 PM
Charles River Laboratories International (Issuer)
Parisotto Shannon M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/30/2024
6:56 PM
Charles River Laboratories International (Issuer)
Pease Flavia (Reporting)
Form 4/A
05/30/2024
7:02 PM
Charles River Laboratories International (Issuer)
Creamer Victoria L (Reporting)
Form 4/A
05/30/2024
6:47 PM
Barbo William D (Reporting)
Charles River Laboratories International (Issuer)
Form 4/A
05/30/2024
5:58 PM
Charles River Laboratories International (Issuer)
FOSTER JAMES C (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/29/2024
4:51 PM
Charles River Laboratories International (Issuer)
Knell Michael Gunnar (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/29/2024
4:46 PM
Charles River Laboratories International (Issuer)
Girshick Birgit (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/29/2024
4:48 PM
Charles River Laboratories International (Issuer)
Creamer Victoria L (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/29/2024
4:34 PM
Charles River Laboratories International (Issuer)
Knell Michael Gunnar (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/29/2024
4:38 PM
Charles River Laboratories International (Issuer)
Pease Flavia (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/29/2024
4:08 PM
Charles River Laboratories International (Issuer)
Creamer Victoria L (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/29/2024
4:10 PM
Charles River Laboratories International (Issuer)
Knell Michael Gunnar (Reporting)
Form 4/A
05/29/2024
3:05 PM
Charles River Laboratories International (Filer)
Form SD
Specialized Disclosure Report  
05/28/2024
4:42 PM
Barbo William D (Reporting)
Charles River Laboratories International (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/28/2024
4:25 PM
Charles River Laboratories International (Issuer)
Girshick Birgit (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/28/2024
4:29 PM
Charles River Laboratories International (Issuer)
LaPlume Joseph W (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/28/2024
4:32 PM
Charles River Laboratories International (Issuer)
Parisotto Shannon M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/16/2024
3:35 PM
Charles River Laboratories International (Issuer)
MASSARO GEORGE (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/15/2024
6:24 PM
Andrews Nancy C (Reporting)
Charles River Laboratories International (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/15/2024
6:30 PM
Charles River Laboratories International (Issuer)
WILSON VIRGINIA M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/15/2024
4:47 PM
Charles River Laboratories International (Issuer)
Thompson Craig B. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/15/2024
4:52 PM
Charles River Laboratories International (Issuer)
MACKAY MARTIN (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/15/2024
4:38 PM
BERTOLINI ROBERT J (Reporting)
Charles River Laboratories International (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/15/2024
4:42 PM
Charles River Laboratories International (Issuer)
WALLMAN RICHARD F (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
URGENT: This Altcoin Opportunity Won’t Wait – Act Now (Ad)

Crypto has officially entered the "banana zone" – that wild phase where prices can 1000x in days. It happens like clockwork every 4 years, during the December to February window of a Bitcoin halving year. This is where fortunes are made – often LITERALLY overnight.

05/15/2024
4:27 PM
Charles River Laboratories International (Issuer)
MASSARO GEORGE (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/15/2024
4:30 PM
Charles River Laboratories International (Issuer)
Llado George Sr. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/15/2024
4:34 PM
Charles River Laboratories International (Issuer)
Kemps-Polanco Reshema (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/14/2024
3:49 PM
Charles River Laboratories International (Issuer)
LaPlume Joseph W (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/10/2024
10:30 AM
Charles River Laboratories International (Subject)
LaPlume Joseph W (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
05/09/2024
3:20 PM
Charles River Laboratories International (Filer)
Form S-3ASR
05/09/2024
8:17 AM
Charles River Laboratories International (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
05/09/2024
6:31 AM
Charles River Laboratories International (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/24/2024
6:30 AM
Charles River Laboratories International (Filer)
Form DEFA14A
03/29/2024
7:00 AM
Charles River Laboratories International (Filer)
Form DEF 14A
03/29/2024
7:01 AM
Charles River Laboratories International (Filer)
Form ARS
03/25/2024
5:48 PM
Barbo William D (Reporting)
Charles River Laboratories International (Issuer)
Form 4/A
03/25/2024
5:52 PM
Charles River Laboratories International (Issuer)
Parisotto Shannon M (Reporting)
Form 4/A
03/25/2024
5:58 PM
Charles River Laboratories International (Issuer)
FOSTER JAMES C (Reporting)
Form 4/A
03/25/2024
6:00 PM
Charles River Laboratories International (Issuer)
Creamer Victoria L (Reporting)
Form 4/A
03/25/2024
4:49 PM
Charles River Laboratories International (Issuer)
Knell Michael Gunnar (Reporting)
Form 4/A
03/25/2024
4:52 PM
Charles River Laboratories International (Issuer)
Girshick Birgit (Reporting)
Form 4/A
03/25/2024
4:55 PM
Charles River Laboratories International (Issuer)
LaPlume Joseph W (Reporting)
Form 4/A
03/11/2024
3:42 PM
Charles River Laboratories International (Issuer)
Knell Michael Gunnar (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/08/2024
1:34 PM
Charles River Laboratories International (Subject)
Knell Michael Gunnar (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/05/2024
3:54 PM
Charles River Laboratories International (Issuer)
Knell Michael Gunnar (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/04/2024
11:47 AM
Charles River Laboratories International (Subject)
Knell Michael Gunnar (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/01/2024
4:37 PM
Charles River Laboratories International (Issuer)
Creamer Victoria L (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/29/2024
2:14 PM
Charles River Laboratories International (Subject)
Creamer Victoria L (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/29/2024
11:42 AM
Charles River Laboratories International (Subject)
Parisotto Shannon M (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/23/2024
3:57 PM
Barbo William D (Reporting)
Charles River Laboratories International (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/22/2024
10:09 AM
Barbo William D (Reporting)
Charles River Laboratories International (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/20/2024
4:28 PM
Charles River Laboratories International (Issuer)
FOSTER JAMES C (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/20/2024
4:32 PM
Charles River Laboratories International (Issuer)
Parisotto Shannon M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/16/2024
5:37 PM
Charles River Laboratories International (Issuer)
Girshick Birgit (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/15/2024
10:02 AM
Charles River Laboratories International (Subject)
LaPlume Joseph W (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/14/2024
8:19 AM
Charles River Laboratories International (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
02/14/2024
6:30 AM
Charles River Laboratories International (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/05/2024
7:31 PM
Charles River Laboratories International (Issuer)
Kemps-Polanco Reshema (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/31/2024
6:35 PM
Charles River Laboratories International (Issuer)
Parisotto Shannon M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/31/2024
6:14 PM
Charles River Laboratories International (Issuer)
Girshick Birgit (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/31/2024
4:34 PM
Charles River Laboratories International (Issuer)
Girshick Birgit (Reporting)
Form 4/A
01/31/2024
4:26 PM
Charles River Laboratories International (Issuer)
Creamer Victoria L (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/31/2024
4:28 PM
Charles River Laboratories International (Issuer)
LaPlume Joseph W (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/31/2024
4:31 PM
Charles River Laboratories International (Issuer)
Knell Michael Gunnar (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/31/2024
4:23 PM
Barbo William D (Reporting)
Charles River Laboratories International (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/31/2024
3:59 PM
Charles River Laboratories International (Issuer)
FOSTER JAMES C (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/31/2024
4:03 PM
Charles River Laboratories International (Issuer)
FOSTER JAMES C (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/24/2024
3:34 PM
Charles River Laboratories International (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/24/2024
1:27 PM
BlackRock Inc. (Filed by)
Charles River Laboratories International (Subject)
Form SC 13G/A
01/16/2024
3:32 PM
Charles River Laboratories International (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/11/2024
3:09 PM
Charles River Laboratories International (Issuer)
Girshick Birgit (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NYSE:CRL) was last updated on 12/22/2024 by MarketBeat.com Staff
From Our Partners